FDA Adverse Event Injury Summary report: N

T:SLIM X2 INSULIN PUMP WITH BASAL-IQ TECHNOLOGY

MDR report key: 9800433 · Received March 6, 2020

Report

Report Number
3013756811-2020-25239
Event Type
Injury
Date Received
March 6, 2020
Date of Event
February 15, 2020
Report Date
March 6, 2020
Manufacturer
TANDEM DIABETES CARE
Product Code
OZO
UDI-DI
00853052007264
PMA / PMN Number
P180008
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

TANDEM QUALITY ENGINEER EVALUATED PUMP DATA AND CONCLUDED THE FOLLOWING: THE CONTINUOUS GLUCOSE MONITOR WAS NOT IN USE ON (B)(6) 2020. THE LOWEST BLOOD GLUCOSE (BG) ENTERED INTO THE PUMP BY THE USER WAS 193 MG/DL ON (B)(6) 2020. THEREFORE, THE COMPLAINT COULD NOT BE CONFIRMED. ON (B)(6) 2020, USER MADE BOLUS REQUESTS WHILE STILL HAVING INSULIN ON BOARD (IOB). MAKING BOLUS REQUESTS WHILE STILL HAVING IOB COULD LEAD TO A LOW BG EVENT. ON (B)(6) 2020, USER MADE BOLUS REQUESTS WITHOUT ENTERING CURRENT BG. MAKING BOLUS REQUESTS WITHOUT ENTERING CURRENT BG COULD LEAD TO A LOW BG EVENT. THERE IS NO EVIDENCE THAT THE PUMP EXPERIENCED A MALFUNCTION OR FAILURE.

Additional Manufacturer Narrative · 1

NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. DEVICE NOT RETURNED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE CUSTOMER EXPERIENCED A LOW BLOOD GLUCOSE (BG) LEVEL OF 36 MG/DL. CAUSE OF LOW BG WAS NOT KNOWN. REPORTEDLY, THE ISSUE MAY HAVE BEEN CAUSED BY PHYSICAL ACTIVITY OR POSSIBLY DELIVERING A BOLUS; HOWEVER THIS COULD NOT BE CONFIRMED. CUSTOMER CONSUMED JUICE AND EGG NOG TO ADDRESS BG. RECOMMENDATION WAS MADE TO CONSULT WITH A HEALTHCARE PROVIDER TO DISCUSS DIABETES MANAGEMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
262320 T:SLIM X2 INSULIN PUMP WITH BASAL-IQ TECHNOLOGY AUTOMATED INSULIN DOSING, THRESHOLD SUSPEND OZO TANDEM DIABETES CARE 1000096 00853052007264

Patients

Seq Age Sex Outcome Treatment
1 61 YR Other